Company: NAVN
Filing Date: 2025-06-20
Form Type: DRS
Source: 0001628279-25-000383
Chunk: 350

Company: Navan, Inc.
Filing Date: 2025-06-20
Form: DRS
Chunk 350
---
 31, |             |     |      |             |
|                                                             |     |              2025 |             |     | 2024 |             |
| Redeemable convertible preferred shares                     |     |                   | 439,080,808 |     |      | 439,080,808 |
| Stock options issued and outstanding                        |     |                   | 122,916,304 |     |      | 125,313,916 |
| RSUs issued and outstanding                                 |     |                   |  13,962,632 |     |      |   2,847,353 |
| Warrants to purchase redeemable convertible preferred stock |     |                   |     120,480 |     |      |     120,480 |
| Shares of common stock subject to repurchase                |     |                   |     149,291 |     |      |     400,020 |
| Convertible notes                                           |     |                   |  38,838,512 |     |      |  41,942,500 |
| Total antidilutive securities                               |     |                   | 615,068,027 |     |      | 609,705,077 |

#### NOTE 16 – SUBSEQUENT EVENTS
During the three months ended April 30, 2025, we issued a term loan and common stock warrants in exchange for cash proceeds of $130.0 million, and also executed Simple Agreements for Future Equity (“SAFEs”) and common stock warrants in exchange for total proceeds of $155.0 million. We also settled the 2022 Promissory Note for a cash payment of $198.1 million. We are in the process of evaluating the accounting impact of these transactions.

During the three months ended April 30, 2025, we amended the Warehouse Credit Facility to extend the maturity date to February 2028. We also repaid the Trade Loan Facility, and executed a new revolving line of credit with Citibank. The new revolving line of credit has a borrowing limit of $100.0

<div align='center'>F-41</div>

million, and a term through March 2028. We are in the process of evaluating the accounting impact of these transactions.

Subsequent events have been evaluated through April 30, 2025, the date the consolidated financial statements were available to be issued.

Events Subsequent to Original Issuance of Financial Statements (Unaudited)

The Company evaluated subsequent events through June 20